Japan Lifeline Co., Ltd. (7575.T)
Tokyo · JPY · Healthcare · Medical Devices
¥1,581 (+0.25%) as of
Key statistics
- Market cap
- 110.91B
- P/E (TTM)
- 11.86
- Forward P/E
- 12.97
- EPS (TTM)
- 133.34
- Dividend yield
- 3.55%
- 52-week range
- 1,239.00 – 1,645.00
- Beta
- 0.23
- Revenue (TTM)
- 60.47B
- Profit margin
- 15.47%
- Analyst target
- ¥1,603.33
- Volume
- 145.70k
About Japan Lifeline Co., Ltd.
Japan Lifeline Co., Ltd., a medical device company, engages in manufacturing and sale of medical device in Japan. The company's cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, disposable ECG recorder, and venous vascular closure system. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts. In addition, the company offers gastrointestinal intervention products, including cholangioscope, biliary tube stent, papillary balloon dilatation catheter, self-expandable duodenal and colonic stent, endoscopic guidewire, and radiofrequency ablation systems; structural heart disease intervention products, such as radiofrequency wires and atrial septal defect closure devices; and embolic coil and aspiration catheter products. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Tokyo, Japan
- Employees
- 1,304
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.